在埃及曼苏拉大学用组织纤溶酶原激活剂治疗急性缺血性中风的第一例报道

IF 0.3 Q4 CRITICAL CARE MEDICINE

Egyptian Journal of Critical Care Medicine Pub Date : 2017-12-01 DOI:10.1016/j.ejccm.2017.10.001

Ahmed Farouk Donia , Nourelsabah Mohamed Elbialy , Nada Abdelhameed Elsaid , Ayman Fathi Refaie

{"title":"在埃及曼苏拉大学用组织纤溶酶原激活剂治疗急性缺血性中风的第一例报道","authors":"Ahmed Farouk Donia , Nourelsabah Mohamed Elbialy , Nada Abdelhameed Elsaid , Ayman Fathi Refaie","doi":"10.1016/j.ejccm.2017.10.001","DOIUrl":null,"url":null,"abstract":"<div><p>Recombinant Tissue Plasminogen Activator (rTPA) is the standard of care for treatment of acute ischemic stroke. Nevertheless, its widespread use in Egypt is hindered by many factors. We report on the first case of acute ischemic stroke to be treated with rTPA at our University hospitals. She received rTPA 4 h and 20 min after the onset of symptoms despite the occurrence of stroke inside the hospital and the availability of rTPA. The patient showed partial improvement after 3 months. We hope that public and medical staff awareness as well as our developing experience relative to treatment of acute ischemic stroke would improve over time allowing for avoidance of long-term suffering of these patients.</p></div>","PeriodicalId":31233,"journal":{"name":"Egyptian Journal of Critical Care Medicine","volume":"5 3","pages":"Pages 99-100"},"PeriodicalIF":0.3000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejccm.2017.10.001","citationCount":"3","resultStr":"{\"title\":\"The first reported case of acute ischemic stroke treated with tissue plasminogen activator at Mansoura University, Egypt\",\"authors\":\"Ahmed Farouk Donia , Nourelsabah Mohamed Elbialy , Nada Abdelhameed Elsaid , Ayman Fathi Refaie\",\"doi\":\"10.1016/j.ejccm.2017.10.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Recombinant Tissue Plasminogen Activator (rTPA) is the standard of care for treatment of acute ischemic stroke. Nevertheless, its widespread use in Egypt is hindered by many factors. We report on the first case of acute ischemic stroke to be treated with rTPA at our University hospitals. She received rTPA 4 h and 20 min after the onset of symptoms despite the occurrence of stroke inside the hospital and the availability of rTPA. The patient showed partial improvement after 3 months. We hope that public and medical staff awareness as well as our developing experience relative to treatment of acute ischemic stroke would improve over time allowing for avoidance of long-term suffering of these patients.</p></div>\",\"PeriodicalId\":31233,\"journal\":{\"name\":\"Egyptian Journal of Critical Care Medicine\",\"volume\":\"5 3\",\"pages\":\"Pages 99-100\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2017-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ejccm.2017.10.001\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Egyptian Journal of Critical Care Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S209073031730035X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S209073031730035X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}

引用次数: 3

摘要

重组组织型纤溶酶原激活剂(rTPA)是治疗急性缺血性脑卒中的标准护理。然而，它在埃及的广泛使用受到许多因素的阻碍。我们报告第一例急性缺血性脑卒中在我们的大学医院用rTPA治疗。患者在出现症状后接受rTPA治疗4 h和20 min，尽管医院内已发生卒中且rTPA可用。3 个月后患者出现部分好转。我们希望公众和医务人员的意识以及我们在急性缺血性中风治疗方面的发展经验将随着时间的推移而改善，从而避免这些患者的长期痛苦。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The first reported case of acute ischemic stroke treated with tissue plasminogen activator at Mansoura University, Egypt

Recombinant Tissue Plasminogen Activator (rTPA) is the standard of care for treatment of acute ischemic stroke. Nevertheless, its widespread use in Egypt is hindered by many factors. We report on the first case of acute ischemic stroke to be treated with rTPA at our University hospitals. She received rTPA 4 h and 20 min after the onset of symptoms despite the occurrence of stroke inside the hospital and the availability of rTPA. The patient showed partial improvement after 3 months. We hope that public and medical staff awareness as well as our developing experience relative to treatment of acute ischemic stroke would improve over time allowing for avoidance of long-term suffering of these patients.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Egyptian Journal of Critical Care Medicine

自引率

0.00%

发文量

审稿时长

42 weeks

期刊介绍： The Egyptian Journal of Critical Care Medicine is the official Journal of the Egyptian College of Critical Care Physicians, the most authoritative organization of Egyptian physicians involved in the multi-professional field of critical care medicine. The journal is intended to provide a peer-reviewed source for multidisciplinary coverage of general acute and intensive care medicine and its various subcategories including cardiac, pulmonary, neuro, renal as well as post-operative care. The journal is proud to have an international multi-professional editorial board in the broad field of critical care that will assist in publishing promising research and breakthrough reports that lead to better patients care in life threatening conditions, and bring the reader a quick access to the latest diagnostic and therapeutic approaches in monitoring and management of critically ill patients.